Domestic pharma cos expected to grow at a CAGR of around 8-10% between FY18-2021

The domestic pharmaceutical industry has gained adequate scale and generic drug development capabilities over a decade of growth which will keep them in good stead to capture bigger opportunities in the regulated market.

from India Infoline News Service http://bit.ly/2ENGd2Q